Is Oncology Institute Inc (TOI) a Stock to Watch After Gaining 21.15% This Week?

Oncology Institute Inc (TOI) stock has gained 21.15% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Oncology Institute Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TOI!

See Full TOI Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TOI Stock Today?

Oncology Institute Inc (TOI) stock has fallen -0.53% while the S&P 500 is higher by 0.14% as of 11:09 AM on Tuesday, Oct 31. TOI has fallen -$0.01 from the previous closing price of $1.90 on volume of 95,726 shares. Over the past year the S&P 500 has gained 7.76% while TOI has fallen -58.37%. TOI lost -$0.67 per share in the over the last 12 months.

More About Oncology Institute Inc

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Click Here to get the full Stock Report for Oncology Institute Inc stock.